THC Biomed Intl Ltd. (THCBF)
OTCMKTS
· Delayed Price · Currency is USD
0.0010
-0.0235 (-95.92%)
May 1, 2025, 4:00 PM EDT
THC Biomed Intl Income Statement
Financials in millions CAD. Fiscal year is August - July.
Millions CAD. Fiscal year is Aug - Jul.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2014 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '23 Apr 30, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 | Jul '20 Jul 31, 2020 | Jul '19 Jul 31, 2019 | Jul '18 Jul 31, 2018 | 2014 - 2017 |
| Revenue | 2.23 | 2.45 | 2.63 | 3.25 | 1.49 | 0.93 | Upgrade
|
| Revenue Growth (YoY) | -9.87% | -6.80% | -19.01% | 117.88% | 60.98% | 1445.43% | Upgrade
|
| Cost of Revenue | 3.39 | 3.48 | 5.8 | 0 | -0.01 | 0.47 | Upgrade
|
| Gross Profit | -1.16 | -1.03 | -3.17 | 3.24 | 1.5 | 0.46 | Upgrade
|
| Selling, General & Admin | 1.56 | 1.54 | 1.47 | 1.63 | 1.8 | 1.67 | Upgrade
|
| Other Operating Expenses | 0 | 0.02 | 0.04 | 0.04 | 0.04 | 0.02 | Upgrade
|
| Operating Expenses | 2.46 | 2.63 | 3.16 | 3.37 | 6.35 | 3.03 | Upgrade
|
| Operating Income | -3.62 | -3.66 | -6.33 | -0.13 | -4.85 | -2.57 | Upgrade
|
| Interest & Investment Income | 0.01 | 0.01 | 0 | 0 | 0 | 0 | Upgrade
|
| Currency Exchange Gain (Loss) | -0 | 0 | -0 | -0.01 | -0.01 | -0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | -0 | 0 | 0 | 0 | -4.46 | -7.66 | Upgrade
|
| EBT Excluding Unusual Items | -3.62 | -3.65 | -6.34 | -0.14 | -9.32 | -10.23 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0 | 0.46 | - | - | -0 | - | Upgrade
|
| Other Unusual Items | -0.05 | 0.13 | -0.02 | -0.03 | -3.38 | -2.23 | Upgrade
|
| Pretax Income | -3.67 | -3.07 | -6.36 | -0.16 | -12.7 | -12.46 | Upgrade
|
| Net Income | -3.67 | -3.07 | -6.36 | -0.16 | -12.7 | -12.46 | Upgrade
|
| Net Income to Common | -3.67 | -3.07 | -6.36 | -0.16 | -12.7 | -12.46 | Upgrade
|
| Shares Outstanding (Basic) | 164 | 164 | 164 | 156 | 133 | 112 | Upgrade
|
| Shares Outstanding (Diluted) | 164 | 164 | 164 | 156 | 133 | 112 | Upgrade
|
| Shares Change (YoY) | -0.75% | 0.21% | 4.79% | 17.69% | 18.08% | 9.95% | Upgrade
|
| EPS (Basic) | -0.02 | -0.02 | -0.04 | -0.00 | -0.10 | -0.11 | Upgrade
|
| EPS (Diluted) | -0.02 | -0.02 | -0.04 | -0.00 | -0.10 | -0.11 | Upgrade
|
| Free Cash Flow | -0.36 | -2.02 | -1.4 | -1.31 | -9.02 | -7.56 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.01 | -0.01 | -0.01 | -0.07 | -0.07 | Upgrade
|
| Gross Margin | -52.14% | -42.03% | -120.76% | 99.95% | 100.51% | 49.47% | Upgrade
|
| Operating Margin | -162.67% | -149.40% | -241.00% | -4.01% | -325.56% | -277.64% | Upgrade
|
| Profit Margin | -164.79% | -125.15% | -241.94% | -4.98% | -852.53% | -1346.42% | Upgrade
|
| Free Cash Flow Margin | -16.06% | -82.36% | -53.39% | -40.43% | -605.61% | -817.34% | Upgrade
|
| EBITDA | -2.99 | -2.95 | -5.51 | 0.75 | -4.26 | -2.41 | Upgrade
|
| EBITDA Margin | -134.30% | -120.54% | -209.69% | 22.98% | -286.22% | -260.21% | Upgrade
|
| D&A For EBITDA | 0.63 | 0.71 | 0.82 | 0.88 | 0.59 | 0.16 | Upgrade
|
| EBIT | -3.62 | -3.66 | -6.33 | -0.13 | -4.85 | -2.57 | Upgrade
|
| EBIT Margin | -162.67% | -149.40% | -241.00% | -4.01% | - | -277.64% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.